WHO's Global TB Report: Here's why India should be worried

In 2015, the country reported 50% more cases of tuberculosis than a year earlier

WHO’s Global TB Report: Here’s why India should be worried
BS Web Team New Delhi
Last Updated : Nov 01 2016 | 9:06 AM IST
Even as the occurrence of tuberculosis and related deaths are on the wane both globally and in India, the epidemic is larger in India than estimated earlier, shows the World Health Organization’s (WHO’s) Global Tuberculosis (TB) Report 2016.

In an indication that the measures taken by the successive central governments in India over the years might have fallen short, India in 2015 recorded 50% more cases of TB than in the previous year. The report shows that 7,234 cases of Extensive Drug Resistance TB (XDR-TB) were reported globally in 2015. India accounted for about 30% of total (2,130), followed by Ukraine (1,206), the Russian Federation (1,205) and South Africa (719). The mortality rate in India and South Africa for such cases was also high (more than 40%).

An estimated 480,000 new cases of Multidrug-Resistant TB (MDR-TB) were reported globally during the year, besides 100,000 people with Rifampicin-Resistant TB (RR-TB) who were eligible for MDR-TB treatments – a total of 580,000. Of them, 45% of all such cases were accounted for by India, China and Russian Federation alone.

Almost 5,000 TB deaths are reported globally on a daily basis, as many patients with MDR-TB are not able to access proper treatment, the report says, adding that India alone accounts for an alarming 1,400 such deaths every day.

The report also reveals that financial aid received by low- and middle-income countries for national TB programmes (NTPs) fall almost $2 billion short of the $8.3 billion required in 2016, and this annual gap could widen to $6 billion by 2020, if the current funding levels do not increase.

Also, considering that the government expenditure on health in 150 countries in 2014 was less than the WHO benchmark of at least 6% of gross domestic product (GDP), the report points to the pressing need for improvements in overall health financing by governments, particularly in the most affected countries like India. 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 01 2016 | 8:58 AM IST

Next Story